Clinical Trials Directory

Trials / Completed

CompletedNCT01783639

Safety and Performance Evaluation of WIRION™ EPD in Patients Undergoing Carotid Artery Stenting

The WISE Study is a Pivotal Study Evaluating the Safety and Performance of WIRION™ EPD in Patients Undergoing Carotid Artery Stenting

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Gardia Medical · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the safety and performance of WIRION™ EPD in patients undergoing carotid artery stenting to a performance goal based on an analysis of the results of previous US IDE carotid stenting with embolic protection studies

Detailed description

Patient registry procedures include: * Clinical Events Committee (CEC); responsibility for validating all reported primary safety outcomes * Data Safety Monitoring Board (DSMB); to review and evaluate safety data including serious adverse events * 100% data monitoring; to compare data entered into the registry * Source data verification; to assess the accuracy, completeness of registry data by comparing the data to external data sources (e.g., medical records, paper or electronic case report forms). * Standard Operating Procedures; to address registry operations and analysis activities, such as patient recruitment, data collection, data management, data analysis and reporting for adverse events. * Sample size assessment to specify the number of participants and follow up duration. * Data Management Plan; to address situations where variables are reported as missing, unavailable, "non-reported," uninterpretable, or considered missing because of data inconsistency or out-of-range results * Statistical analysis plan; describing the analytical principles and statistical techniques to be employed in order to address the primary and secondary objectives, as specified in the study protocol or plan.

Conditions

Interventions

TypeNameDescription
PROCEDURECarotid Artery StentAssessment of the study device (WIRION) during carotid artery stenting procedure in comparison to a performance of FDA approved filter type embolic protection devices

Timeline

Start date
2013-02-01
Primary completion
2013-12-01
Completion
2015-04-01
First posted
2013-02-05
Last updated
2017-08-07
Results posted
2015-07-22

Locations

10 sites across 3 countries: Belgium, Germany, Italy

Source: ClinicalTrials.gov record NCT01783639. Inclusion in this directory is not an endorsement.